Effect of Liuzijue Qigong Exercises on Ventilatory Function in Post Stroke Elderly Patients

NCT ID: NCT07153562

Last Updated: 2025-09-17

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

70 participants

Study Classification

INTERVENTIONAL

Study Start Date

2025-01-01

Study Completion Date

2025-08-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

to investigate the effect of Liuzijue Qigong exercises on ventilatory function in post stroke elderly patients.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

70 post stroke patients their ages ranges from 60 to 70 years old, randomly assigned into two groups: Study group (A) that consists of 35 patients (18 women \&17 men) who perform Liuzijue exercise, 5 sessions per week, 20 minutes per session. and conventional rehabilitation treatment 3 sessions per week, 45-60 minutes per session, for 12 successive weeks.

Control group (B) that consists of 35 patients (18 women \&17 men) in which patients receive just the conventional exercise program, 3 sessions per week, 45-60 minutes per session, for 12 successive weeks.

During the study, the participants receive study information form, instructions and signed the consent form.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Ventilatory Function Functional Capacity Motor Function Sleep Quality Quality of Life

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

SINGLE

Participants
Participants will be assigned randomly into two groups of equal number . the randomization will be performed by computerized randomization.

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Liuzijue Qigong

35 patients will perform : Liuzijue exercise for 20 minutes, 5 times per week, Beside conventional rehabilitation exercises, 3 sessions per week, 45-60 minutes per session, for 12 successive weeks.

Group Type EXPERIMENTAL

liuzijue qigong exercises

Intervention Type OTHER

Liuzijue qigong exercise for 20 minutes, 5 times per week, for 12 successive weeks.

conventional rehabilitation treatment

Intervention Type OTHER

conventional rehabilitation exercises, 3 sessions per week, 45-60 minutes per session, for 12 successive weeks.

Conventional rehabilitation

35 patients will do only conventional rehabilitation exercises, 3 sessions per week, 45-60 minutes per session, for 12 successive weeks.

Group Type ACTIVE_COMPARATOR

conventional rehabilitation treatment

Intervention Type OTHER

conventional rehabilitation exercises, 3 sessions per week, 45-60 minutes per session, for 12 successive weeks.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

liuzijue qigong exercises

Liuzijue qigong exercise for 20 minutes, 5 times per week, for 12 successive weeks.

Intervention Type OTHER

conventional rehabilitation treatment

conventional rehabilitation exercises, 3 sessions per week, 45-60 minutes per session, for 12 successive weeks.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

All patients included in this study met the following criteria:

1. Subject people of both sexes (18 women, and 17 men).
2. All patients had unilateral stroke.
3. Their age ranged from 60 to 80 years old.
4. Stroke onset was from 6 to 1 months.
5. Medically stable subjects.
6. Non-smoker subjects.
7. Ability to understand and follow simple verbal instructions.

Exclusion Criteria

Patients who experienced or had one or more of the following were excluded from the study:

1. Patients with severe acute illness.
2. Chronic unstable pulmonary and/or cardiac disease.
3. Impaired level of consciousness and evidence of gross cognitive problems.
4. Patients undergo chemotherapy.
5. Active hemoptysis, untreated pneumothorax, recent esophageal surgery.
6. Recent oral, facial or skull trauma / surgery, acute sinusitis, epistaxis, hemodynamic instability.
7. Current Smokers.
8. Patients had a severe psychological disorder.
Minimum Eligible Age

60 Years

Maximum Eligible Age

80 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Cairo University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Aia Muhammad Ibrahem

assistant lecturer of physical therapy

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Azza Abdelaziz Abdelhady, Professor of Physical Therapy

Role: STUDY_DIRECTOR

faculty of physical therapy

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Faculty of Physical Therapy

Dokki, Giza Governorate, Egypt

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Egypt

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

012/005865

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.